132 related articles for article (PubMed ID: 36483060)
1. An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
Schiff JP; Lee Y; Wang Y; Perkins SM; Kessel SK; Fitzgerald TJ; Larrier NA; Michalski JM
Adv Radiat Oncol; 2023; 8(1):101083. PubMed ID: 36483060
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials.
Donahue B; Marymont MA; Kessel S; Iandoli MK; Fitzgerald T; Holmes E; Kocak M; Boyett JM; Gajjar A; Packer RJ
Front Oncol; 2012; 2():185. PubMed ID: 23316474
[TBL] [Abstract][Full Text] [Related]
3. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Walser M; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Rutkowski S; Timmermann B; Kortmann RD
Strahlenther Onkol; 2021 Aug; 197(8):674-682. PubMed ID: 33226469
[TBL] [Abstract][Full Text] [Related]
5. Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
Michalski JM; Janss AJ; Vezina LG; Smith KS; Billups CA; Burger PC; Embry LM; Cullen PL; Hardy KK; Pomeroy SL; Bass JK; Perkins SM; Merchant TE; Colte PD; Fitzgerald TJ; Booth TN; Cherlow JM; Muraszko KM; Hadley J; Kumar R; Han Y; Tarbell NJ; Fouladi M; Pollack IF; Packer RJ; Li Y; Gajjar A; Northcott PA
J Clin Oncol; 2021 Aug; 39(24):2685-2697. PubMed ID: 34110925
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.
Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C
J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433
[TBL] [Abstract][Full Text] [Related]
7. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
8. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
9. The Advantage of Proton Therapy in Hypothalamic-Pituitary Axis and Hippocampus Avoidance for Children with Medulloblastoma.
Aljabab S; Rana S; Maes S; O'Ryan-Blair A; Castro J; Zheng J; Halasz LM; Taddei PJ
Int J Part Ther; 2022; 8(3):43-54. PubMed ID: 35127975
[TBL] [Abstract][Full Text] [Related]
10. Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.
Noble DJ; Ajithkumar T; Lambert J; Gleeson I; Williams MV; Jefferies SJ
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):439-447. PubMed ID: 28318880
[TBL] [Abstract][Full Text] [Related]
11. Comparative dosimetric analysis of volumetric modulated arc therapy based craniospinal irradiation plans between Halcyon ring gantry and TrueBeam C-arm linear accelerator.
Sarkar B; Biswal SS; Shahid T; Ghosh T; Bhattacharya J; De A; Mukherjee M; Ganesh T; Cozzi L
Sci Rep; 2023 Mar; 13(1):3430. PubMed ID: 36859485
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison of short and full arc in spinal PTV in volumetric-modulated arc therapy-based craniospinal irradiation.
Sarkar B; Munshi A; Ganesh T; Manikandan A; Mohanti BK
Med Dosim; 2020 Spring; 45(1):1-6. PubMed ID: 30995966
[TBL] [Abstract][Full Text] [Related]
15. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.
Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
Suzuki S; Kato T; Murakami M
J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
19. Technique for sparing previously irradiated critical normal structures in salvage proton craniospinal irradiation.
McDonald MW; Wolanski MR; Simmons JW; Buchsbaum JC
Radiat Oncol; 2013 Jan; 8():14. PubMed ID: 23311343
[TBL] [Abstract][Full Text] [Related]
20. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
